Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

A woman's complete hair loss condition improved after recovering from COVID-19.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Yoga Prana Vidya healing can effectively treat hair loss in children.

Yoga Prana Vidya healing can effectively treat hair loss in children.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Alopecia Areata affects both patients and their cohabitants' quality of life and emotional well-being.

Exosomes can help promote hair growth and may treat hair loss.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.